MedPath

Heparin Dose for Radial Angiography

Phase 4
Completed
Conditions
Coronary Angiograph
Interventions
Registration Number
NCT01634438
Lead Sponsor
University of Alberta
Brief Summary

At present, coronary angiogram is usually performed either through an artery in your groin or wrist. An important limitation of the wrist approach is an increase rate of blockage of the wrist artery. It is possible that the dose of blood thinner (i.e. heparin) may decrease the risk of blockage. Early studies seem to suggest that higher dose is required to reduce the risk of this important complication. However, to date there has not been a definitive study to determine the most appropriate heparin dose for the prevention of this complication. The main goal of this study is to determine the appropriate heparin dose to prevent wrist artery blockage and to determine risk factors for developing such a complication.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • Patients older than 18 years of age who were referred for either urgent or elective cardiac catheterization were eligible for the study if a normal Allen's test was demonstrated
Exclusion Criteria
  • myocardial infarction with shock,
  • ST-elevation myocardial infarction,
  • patients undergoing planned percutaneous coronary intervention, and
  • patients in whom transradial approach is contraindicated such as hemodialysis patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
low dose heparinunfractionated heparin30 units per kilogram of unfractionated heparin
High dose heparinunfractionated heparin70 units per kilogram of unfractionated heparin (UFH) intravenously
Primary Outcome Measures
NameTimeMethod
radial artery occlusionone month

The primary endpoint was radial artery occlusion defined as absence palpable radial artery with no flow as assessed by Doppler study

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mazankowski Alberta Heart Institute

🇨🇦

Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath